Our latest news
-
DefiniGEN Achieves ISO 9001: (2015) Certification
29 Jul 2021
-
DefiniGEN appoints Dr Ben Cons as Chairman of its Board
29 Apr 2021
-
DefiniGEN Secures £3.25 million in Funding to Fast-Track Growth
19 Nov 2020
-
DefiniGEN launches tool for coronavirus-specific intestinal cell research
14 May 2020
-
InSphero and DefiniGEN Receive Eurostars Grant to Develop Human Stem Cell-derived Screening Platform for Diabetes Drug Discovery
24 Sep 2019
-
ERS Genomics CRISPR License Agreement
4 Jan 2019
-
Attending World Preclinical Congress 2018
30 Nov 2018
